Sunvozertinib dosage and usage

Suvozertinib (Sunvozertinib) is a third-generation EGFRtyrosine kinase inhibitor (EGFR-TKI) independently developed in China and has been included in medical insurance. It is mainly used to treat patients with EGFR 20 exon insertion mutations (Exon 20ins) non-small cell lung cancer (NSCLC) patients. Correctly mastering the usage and dosage of this drug is of great significance to ensure efficacy and reduce adverse reactions. According to the drug instructions and clinical studies, the currently recommended standard dose is 200 mg once a day orally. The specific dose should still be adjusted by the doctor based on the patient's weight, tolerance and condition.

There is no strict requirement for the taking time of suvotinib, and it can be taken before or after meals. However, in order to reduce gastrointestinal irritation, it is recommended to take it within 30 minutes after a meal, with enough warm water to facilitate drug absorption. When taking the medicine, the tablet should be swallowed whole. It is not recommended to break or chew it to avoid affecting the sustained-release properties of the medicine or increasing gastrointestinal discomfort.

During the treatment, if the patient experiences side effects (such as rash, diarrhea, abnormal liver function, etc.), the doctor may adjust the dose according to the actual situation. Commonly adjusted doses are 200mg or 100mg. If serious adverse reactions occur, the medication may need to be suspended or permanently discontinued. This should be done under the guidance of a doctor, and patients are not allowed to change the medication plan on their own. In addition, if the patient forgets to take the medication during a certain dose, it is recommended to take it as soon as possible on the same day. However, if it is close to the next dose time, the medication should not be repeated to avoid overdose.

In short, suvotinib should be taken strictly according to the dosage prescribed by the doctor, and the regimen should be reviewed regularly and adjusted based on efficacy and tolerance. During long-term use, it is recommended to regularly monitor blood routine, liver and kidney function, and imaging examinations to ensure medication safety. If patients experience any discomfort during medication, they should communicate with the attending doctor in a timely manner and should not stop medication or change medications without authorization.

Reference materials:https://www.drugs.com/

xa0